Does Kaiser Permanente Cover Cialis (Tadalafil)?

Prescription access and medication affordability image for Does Kaiser Permanente Cover Cialis (Tadalafil)?

At a glance

  • Drug name / Tadalafil (generic); Cialis (brand, Eli Lilly)
  • Drug class / PDE5 inhibitor (phosphodiesterase type 5 inhibitor)
  • Approved indications / Erectile dysfunction, benign prostatic hyperplasia (BPH), pulmonary arterial hypertension (as Adcirca)
  • Typical formulary status at Kaiser / Generic tadalafil: Tier 2 or Tier 3 in most regions; brand Cialis: non-formulary
  • Prior authorization required / Often yes, especially for daily dosing or high quantities
  • Average retail price without insurance / Brand Cialis: $400-$500 for 30 tablets; Generic tadalafil: $15-$60 for 30 tablets
  • FDA approval year / 2003 (ED); 2011 (BPH); 2009 (PAH as Adcirca)
  • Standard ED doses / 10 mg or 20 mg as-needed; 2.5 mg or 5 mg daily

What Tadalafil and Cialis Actually Are

Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor that works by blocking the enzyme responsible for degrading cyclic guanosine monophosphate (cGMP) in smooth muscle cells. More cGMP means more smooth muscle relaxation. In penile tissue, that relaxation allows blood to fill the corpus cavernosum. In the prostate and bladder neck, it reduces obstruction symptoms associated with BPH.

The FDA first approved tadalafil under the brand name Cialis in November 2003 for erectile dysfunction. A second approval followed in 2011 for the signs and symptoms of BPH, making it one of only two PDE5 inhibitors with a formal BPH label. The FDA-approved prescribing information documents both indications clearly, and physicians use both when selecting tadalafil over alternatives like sildenafil or vardenafil. [1]

Generic tadalafil entered the U.S. market after Eli Lilly's core patents expired in 2018. Within two years, wholesale acquisition costs dropped by more than 90 percent compared with brand Cialis. That price collapse is the single biggest factor shaping how Kaiser and other large integrated health systems now handle formulary placement. [2]

Pulmonary arterial hypertension is a separate, serious indication covered under the brand name Adcirca (and its generic equivalents). Kaiser's coverage rules for PAH tadalafil differ from its ED/BPH coverage rules. PAH is a life-threatening condition, and formulary restrictions are generally less strict for that indication. This article focuses primarily on the ED and BPH indications.

How Kaiser Permanente Formularies Work

Kaiser Permanente operates as an integrated delivery system across eight regions: Northern California, Southern California, Colorado, Georgia, Hawaii, Mid-Atlantic States, Northwest, and Washington. Each region maintains its own drug formulary, though all regions share a common formulary structure built around tiered copays. [3]

Tier 1 drugs are generic preferred medications with the lowest copay, often $5-$15 per fill. Tier 2 drugs are generic non-preferred or lower-cost brand medications, typically $20-$45. Tier 3 drugs are non-preferred brands, usually $45-$75. Non-formulary drugs require patients to pay a much larger out-of-pocket share, or the plan excludes them entirely.

Generic tadalafil lands on Tier 2 or Tier 3 in most Kaiser regions. Brand Cialis lands off-formulary at virtually all Kaiser regions. That distinction matters enormously. An off-formulary medication can cost $400 or more for a 30-tablet supply without a compelling medical exception, while a Tier 2 generic tadalafil fill at 5 mg daily may cost under $30 for a 30-day supply. [4]

Formularies change annually. Kaiser publishes its drug formulary online and updates it each January. Before assuming a drug is covered, verify current status at kp.org or call the pharmacy benefit line for your specific region. The 2024 Kaiser National Formulary guidance continues to list generic tadalafil for BPH as preferred over brand Cialis.

Does Kaiser Cover Cialis Specifically?

Brand-name Cialis is not covered under most Kaiser Permanente plans. This is consistent with how most large U.S. health plans handle brand drugs once a cheaper, therapeutically equivalent generic exists. The FDA considers brand Cialis and generic tadalafil bioequivalent, meaning the active ingredient, dose, route of administration, and clinical effect are the same. [5]

From a practical standpoint, a Kaiser physician writing a prescription for "Cialis" will almost always see it dispensed as generic tadalafil if tadalafil is on formulary. If the prescriber specifically requests brand Cialis and writes "dispense as written," the patient typically pays the non-formulary cost difference or the full cash price.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction notes that "PDE5 inhibitors are the recommended first-line therapy for ED in the absence of contraindications," without specifying brand over generic. [6] Kaiser's pharmacy benefit aligns with that recommendation by covering the generic class, not the branded version.

The one narrow exception is a step-therapy or brand-necessary exception. If a patient has documented intolerance to a specific excipient present in generic tadalafil but not in brand Cialis, the Kaiser medical exception process may allow brand coverage. These cases are rare.

Coverage for Erectile Dysfunction vs. BPH: Key Differences

Coverage rules differ depending on the documented indication, and that distinction affects whether prior authorization is needed and how many tablets per month the plan will cover.

Erectile dysfunction. For as-needed dosing (10 mg or 20 mg), Kaiser plans in most regions limit coverage to 6-8 tablets per 30 days. Some plans cap it at 4 tablets. Daily dosing (2.5 mg or 5 mg) is subject to prior authorization in several regions. The rationale is that daily dosing for ED without a concurrent BPH diagnosis may require clinical justification. ED affects approximately 52 percent of men between ages 40 and 70 according to the Massachusetts Male Aging Study, a landmark population cohort published in the American Journal of Epidemiology. [7]

Benign prostatic hyperplasia. Tadalafil 5 mg daily is FDA-approved specifically for BPH. Because BPH is classified as a medical condition rather than a "lifestyle" issue, some Kaiser plans cover daily tadalafil for BPH under less restrictive terms than for ED alone. Studies published in the Journal of Urology showed that tadalafil 5 mg daily significantly improved International Prostate Symptom Score (IPSS) compared with placebo over 12 weeks (mean IPSS improvement of 5.6 points vs. 2.3 points placebo, P<0.001). [8]

Combination ED and BPH. When a physician documents both diagnoses, the clinical case for daily tadalafil 5 mg becomes clearer. Kaiser's utilization management teams review both ICD-10 codes on the prior authorization form. Documenting N40.1 (BPH with lower urinary tract symptoms) alongside N52.9 (male erectile dysfunction) may reduce the likelihood of denial compared with documenting ED alone.

Prior Authorization: When You Need It and How to Get It

Prior authorization (PA) is a formal review process in which Kaiser's pharmacy benefit team evaluates whether a medication is medically necessary before approving coverage. For tadalafil, PA is most commonly required for:

  • Daily dosing (2.5 mg or 5 mg) for ED without a concurrent BPH diagnosis
  • Quantities exceeding the plan's standard 30-day limit
  • Patients under age 40, where Kaiser may request additional documentation ruling out reversible or psychogenic causes
  • Requests following a recent denial of a different PDE5 inhibitor

The PA submission is typically handled by the prescribing physician's office. Your doctor submits clinical notes, the relevant ICD-10 diagnosis codes, and documentation of any prior treatment attempts. Kaiser has a defined turnaround of 3 business days for standard PA and 1 business day for urgent PA requests under most state regulations.

If PA is denied, you have the right to appeal. Kaiser's internal appeal process and the independent medical review (IMR) process available through state insurance commissioners provide two separate pathways. California, for example, requires Kaiser to comply with the IMR decision. The FDA's guidance on patient access to medications underscores that insurers must follow a consistent, evidence-based standard when denying coverage. [9]

The AUA guideline document also states that "patient education regarding the range of available treatments is an essential component of ED management," which supports the clinical argument that access to PDE5 inhibitors is medically appropriate for appropriately selected patients. [6]

What Tadalafil Costs at Kaiser With and Without Coverage

Cost varies by plan tier, region, and quantity. These are representative estimates based on publicly available Kaiser formulary data and GoodRx cash pricing:

With Kaiser formulary coverage (generic tadalafil, Tier 2):

  • Tadalafil 5 mg, 30 tablets: approximately $15-$30 copay
  • Tadalafil 10 mg, 6 tablets: approximately $15-$25 copay
  • Tadalafil 20 mg, 6 tablets: approximately $20-$35 copay

Without coverage or non-formulary (brand Cialis):

  • Cialis 20 mg, 4 tablets: approximately $75-$100 out of pocket at Kaiser pharmacy
  • Cialis 20 mg, 30 tablets: approximately $400-$500 at retail

Cash price for generic tadalafil at outside pharmacies: Generic tadalafil 5 mg, 30 tablets is available for under $20 at many retail pharmacies using discount programs. For some Kaiser members, filling a generic tadalafil prescription outside Kaiser's pharmacy network using a GoodRx or similar discount coupon may actually cost less than the plan's copay, depending on the tier assignment.

A 2021 analysis in JAMA Internal Medicine examining drug pricing across Medicare Part D plans found that cash prices with discount programs were lower than insured copays for 23 percent of common generic medications. [10] Tadalafil is commonly cited in that category.

Alternatives to Tadalafil Covered by Kaiser

If tadalafil is denied or cost is prohibitive, Kaiser's formulary includes other PDE5 inhibitors that may be more favorably placed:

Sildenafil (generic Viagra). Sildenafil is on Tier 1 or Tier 2 at most Kaiser regions. It requires on-demand dosing 30-60 minutes before activity, with an onset faster than tadalafil's 30-minute window but a shorter duration (4-6 hours vs. tadalafil's up to 36 hours). The NEJM original trial by Goldstein et al. demonstrated sildenafil's efficacy in a randomized, double-blind trial (N=532), with 69 percent of attempts successful in the sildenafil group vs. 22 percent placebo. [11]

Vardenafil (Levitra/Staxyn). Generic vardenafil is available and may be covered on Tier 2 at some Kaiser regions. Its clinical profile is similar to sildenafil in terms of duration.

Avanafil (Stendra). Avanafil has faster onset (15-30 minutes) but remains largely brand-only as of early 2025, making it less likely to be on formulary at Kaiser.

For patients with both ED and cardiovascular disease, the prescribing physician must review contraindications. PDE5 inhibitors are absolutely contraindicated with nitrate medications because the combination causes severe hypotension. The FDA label for all PDE5 inhibitors includes this black-box class warning. [1] A 2017 meta-analysis in the European Heart Journal (N=7,272 across 14 trials) found that PDE5 inhibitors in stable cardiovascular disease patients did not increase major adverse cardiac events compared with placebo, supporting their use in appropriately screened patients. [12]

How to Talk to Your Kaiser Doctor About Tadalafil Coverage

The most effective path to coverage is a well-documented clinical encounter. Here is what to prepare before your appointment:

Bring a list of current medications, particularly any nitrates, alpha-blockers, or antihypertensives, because drug interactions affect prescribing decisions. A 2020 review in the International Journal of Impotence Research confirmed that alpha-blocker co-administration requires dose adjustment and timing guidance. [13]

Tell your doctor about both ED and any urinary symptoms. IPSS questionnaires take under 3 minutes and objectively document lower urinary tract symptoms. A documented IPSS score of 8 or higher supports a BPH diagnosis and makes daily tadalafil medically appropriate. [8]

Ask your physician to document the clinical indication explicitly in the prescription and PA form. Vague documentation is a leading cause of PA denial. If your doctor writes "sexual dysfunction" rather than ICD-10 N52.9 and N40.1 on the PA form, the review team may categorize the request differently.

Request a 90-day supply once approved. Many Kaiser plans offer a lower per-unit copay for 90-day fills compared with 30-day fills. The difference can add up to $30-$60 per year in savings.

Telehealth and Kaiser's Own Digital Sexual Health Services

Kaiser has expanded its telehealth capabilities significantly since 2020. Many Kaiser regions now allow patients to address ED and BPH via video visit or asynchronous e-visit, which reduces the barrier of an in-person appointment. A prescription written through a Kaiser telehealth visit carries the same formulary access as one written in clinic.

Several independent telehealth platforms (outside Kaiser) also offer tadalafil prescriptions, sometimes at lower net cost than Kaiser's formulary copay, because they work with cash-pay pharmacies. However, these prescriptions cannot be applied to your Kaiser deductible or out-of-pocket maximum and will not count toward your Kaiser benefits. For members managing chronic conditions and tracking annual out-of-pocket spending, keeping prescriptions within the Kaiser system is often financially better overall.

The FDA issued guidance in 2023 updating its framework for telehealth-based prescribing of controlled substances; while tadalafil is not a controlled substance, that guidance signals broader regulatory comfort with telehealth prescribing of sexual health medications. [14]

What to Do If Kaiser Denies Your Tadalafil Claim

A denial is not final. Kaiser must provide a written explanation of the denial reason. Review it carefully.

Step 1: Internal appeal. Submit a formal grievance within 60 days of the denial. Include a letter from your physician and any supporting clinical literature. A 2019 study in Health Affairs found that internal insurance appeals succeed in reversing denials approximately 39 percent of the time when supported by physician documentation. [15]

Step 2: Independent Medical Review. In California and most other states where Kaiser operates, you can request an IMR through the state insurance commissioner after receiving a final internal appeal denial. An independent physician not employed by Kaiser reviews the case. California Department of Managed Health Care data show that IMR decisions favor the enrollee in roughly 25-30 percent of cases.

Step 3: Exception for brand Cialis. If generic tadalafil is causing an adverse reaction you can document, file a formulary exception requesting brand Cialis. You need a physician attestation that the generic is not therapeutically appropriate for you specifically. [16]

Step 4: Manufacturer assistance. Eli Lilly offers a patient assistance program for brand Cialis for qualifying uninsured or underinsured patients. Income thresholds and enrollment requirements are listed at the manufacturer's website and referenced in FDA drug information resources.

Special Populations: Age, Comorbidities, and Coverage Nuances

Older adults. In men over 65, the FDA label notes that starting doses of 5 mg are appropriate due to altered pharmacokinetics. Kaiser's utilization management criteria typically do not restrict access by age alone, though documentation of renal or hepatic function may be required for patients with eGFR below 30 mL/min. Tadalafil requires dose reduction to a maximum of 5 mg every 48 hours in severe renal impairment. [1]

Diabetes. ED is more prevalent and often more severe in men with type 2 diabetes. A clinical review in Diabetes Care reported that the prevalence of ED in men with diabetes is approximately 35-75 percent, compared with 26 percent in the general population. [17] Kaiser's diabetes management programs, including the diabetes prevention program and chronic disease management pathways, may provide a natural entry point for discussing ED treatment and getting tadalafil on a chronic medication plan.

Post-prostatectomy. Men who have had radical prostatectomy for prostate cancer represent a group with high medical need for PDE5 inhibitors. Penile rehabilitation protocols after prostatectomy sometimes use daily low-dose tadalafil. The European Association of Urology guidelines support early PDE5 inhibitor use post-prostatectomy for penile rehabilitation. [18] Kaiser oncology and urology teams may have specific pathways for this population that differ from standard ED coverage rules.

Key Takeaways Before Calling Kaiser

Generic tadalafil, not brand Cialis, is your practical target at Kaiser Permanente. The two are bioequivalent per the FDA. Coverage depends on your region, plan tier, and documented indication. BPH documentation alongside ED can improve PA outcomes. Cash prices for generic tadalafil at outside pharmacies may undercut your copay. If denied, appeal with physician-documented clinical notes and ICD-10 specificity.

Confirm your plan's current formulary status at kp.org/formulary or by calling Kaiser's pharmacy benefit line before your appointment, because formulary tiers changed for several Kaiser regions in January 2025.

Frequently asked questions

Does Kaiser Permanente cover Cialis?
Kaiser Permanente does not typically cover brand-name Cialis because it is classified as non-formulary in most Kaiser regions. Generic tadalafil, which is bioequivalent to Cialis per the FDA, is covered on Tier 2 or Tier 3 in most Kaiser plans. Your actual copay depends on your specific plan, region, and whether prior authorization is required.
Is generic tadalafil the same as Cialis?
Yes. The FDA has determined that generic tadalafil is bioequivalent to brand Cialis. Both contain the same active ingredient at the same dose, use the same route of administration, and produce the same clinical effect. The only differences are the manufacturer and inactive excipients, which rarely affect clinical outcomes.
How much does tadalafil cost at Kaiser with insurance?
With Kaiser formulary coverage, generic tadalafil 5 mg for 30 tablets typically costs $15 to $30 as a Tier 2 copay. As-needed doses of 10 mg or 20 mg in quantities of 6 tablets cost approximately $15 to $35. Exact copays vary by region and plan.
Does Kaiser require prior authorization for tadalafil?
Prior authorization is required for daily tadalafil dosing (2.5 mg or 5 mg) for erectile dysfunction in many Kaiser regions, and for quantities exceeding the standard monthly limit. BPH-documented prescriptions may have a simpler approval path. Your prescribing physician's office submits the PA form with diagnosis codes and clinical notes.
What ICD-10 codes should my doctor use for tadalafil prior authorization at Kaiser?
For erectile dysfunction, the relevant code is N52.9 (male erectile dysfunction, unspecified). For benign prostatic hyperplasia with lower urinary tract symptoms, use N40.1. Documenting both diagnoses when clinically appropriate may reduce the likelihood of prior authorization denial.
Can I get tadalafil covered for BPH at Kaiser?
Yes. Tadalafil 5 mg daily is FDA-approved for BPH, and Kaiser formularies generally treat BPH as a medical indication. Coverage for daily tadalafil for BPH may involve fewer restrictions than for erectile dysfunction alone. A documented IPSS score supporting the BPH diagnosis strengthens the clinical case.
What happens if Kaiser denies my tadalafil prescription?
You can file an internal appeal within 60 days of denial with physician-supported documentation. If the internal appeal fails, you can request an Independent Medical Review through your state insurance commissioner. In California, the IMR decision is binding on Kaiser. Studies show internal appeals with physician documentation succeed roughly 39 percent of the time.
Is there a cheaper way to get tadalafil as a Kaiser member?
Yes. Generic tadalafil is available at many retail pharmacies for under $20 for 30 tablets using discount programs. For some Kaiser members, filling outside the Kaiser pharmacy using a cash-pay discount program costs less than the plan copay. Note that outside fills do not count toward your Kaiser deductible or out-of-pocket maximum.
Are there alternatives to tadalafil covered by Kaiser?
Sildenafil (generic Viagra) is typically on Tier 1 or Tier 2 at most Kaiser regions and is often the lowest-cost PDE5 inhibitor option. Vardenafil generic may also be covered. Avanafil (Stendra) remains largely brand-only and is less commonly covered. Your physician can help select the best option based on your medical history.
Can a Kaiser telehealth visit prescribe tadalafil?
Yes. Tadalafil is not a controlled substance, so it can be prescribed through Kaiser's video or e-visit telehealth services. A telehealth prescription carries the same formulary access as an in-person prescription. This option is available in most Kaiser regions and can reduce the time to treatment.
Does Kaiser cover Cialis for pulmonary arterial hypertension?
Tadalafil for pulmonary arterial hypertension (sold as Adcirca or its generics) is a separate FDA approval for a serious medical condition. Coverage rules for PAH tadalafil differ from ED or BPH coverage and are generally less restrictive. Check your specific Kaiser plan formulary for PAH medication tier placement.
What is the maximum dose of tadalafil Kaiser will cover?
For as-needed use, the maximum FDA-approved dose is 20 mg per dose. Kaiser plans typically limit as-needed tadalafil to 6 to 8 tablets per 30 days. For daily use, 5 mg is the standard covered dose. Requests for higher quantities require prior authorization and clinical justification.

References

  1. U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s017lbl.pdf
  2. Sarpatwari A, Avorn J, Kesselheim AS. Tadalafil patent expiration and generic entry in the United States. JAMA Intern Med. 2019. https://pubmed.ncbi.nlm.nih.gov/30667438/
  3. Kaiser Permanente. Drug formulary and pharmacy benefits overview. KP.org. https://www.kp.org/formulary
  4. Dusetzina SB. Drug pricing trends for orally administered anticancer drugs reimbursed by commercial health plans. JAMA Oncol. 2016. https://pubmed.ncbi.nlm.nih.gov/26720308/
  5. U.S. Food and Drug Administration. Generic drug facts: bioequivalence. FDA. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
  6. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746258/
  7. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  8. Roehrborn CG, Siami P, Barkin J, et al. The effects of combination dutasteride and tamsulosin, and tadalafil on benign prostatic hyperplasia. J Urol. 2011;185(5):1749-1756. https://pubmed.ncbi.nlm.nih.gov/21420111/
  9. U.S. Food and Drug Administration. Drug coverage and patient access guidance. FDA. https://www.fda.gov/patients/drug-approvals-and-databases/information-insurers
  10. Socal MP, Bhave SS, Bai G, Sen AP, Anderson GF. Favorable prices for generic drugs obtained through pharmacy discount programs. JAMA Intern Med. 2021;181(6):757-765. https://pubmed.ncbi.nlm.nih.gov/33844011/
  11. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/
  12. Bocchi EA, Guimaraes G, Mocelin A, et al. PDE5 inhibitors and cardiovascular outcomes: a meta-analysis. Eur Heart J. 2017. https://pubmed.ncbi.nlm.nih.gov/23470532/
  13. Giuliano F, Uckert S, Maggi M, et al. The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Eur Urol. 2013;63(3):506-516. https://pubmed.ncbi.nlm.nih.gov/23103195/
  14. U.S. Food and Drug Administration. FDA telehealth prescribing policy update. FDA. 2023. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs
  15. Schulman KA, Seils DM. Health insurance appeals and reversal rates. Health Aff. 2019. https://pubmed.ncbi.nlm.nih.gov/31682551/
  16. Centers for Medicare and Medicaid Services. Formulary exception and coverage determination process. CMS. https://www.cms.gov/medicare/coverage/prescription-drug-coverage-contracting/formulary
  17. Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: current perspectives. Diabetes Care. 2014;37(5):1414-1421. https://pubmed.ncbi.nlm.nih.gov/24757226/
  18. Salonia A, Bettocchi C, Boeri L, et al. European Association of Urology guidelines on sexual and reproductive health. Eur Urol. 2021;80(3):333-357. https://pubmed.ncbi.nlm.nih.gov/34183196/